Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-033677
Filing Date
2016-11-16
Accepted
2016-11-16 16:10:07
Documents
1
Period of Report
2016-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6738
  Complete submission text file 0000899243-16-033677.txt   8148
Mailing Address PORTOLA PHARMACEUTICALS, INC. 270 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
HOMCY CHARLES J (Reporting) CIK: 0001192591 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37539 | Film No.: 162002533

Mailing Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080
Business Address 400 EAST JAMIE COURT, SUITE 101 SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Issuer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations